Watson Restructuring To Create Brand, Generic Units
Executive Summary
Watson believes it may take up to six months to complete its search for two presidents to head up the company's new brand and generic business units
You may also be interested in...
Ex-Watson COO joins Cardinal
Cardinal Health names former Watson COO Joseph Papa as CEO-pharmaceutical technologies and services business. Papa will be responsible for drug development, formulation, sterile manufacturing, packaging and marketing services. Papa chose not to remain at Watson as president-brand business under the company's reorganization (1"The Pink Sheet" Nov. 1, 2004, p. 22)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011